Fresenius Medical Care AG (FMEd)
FRA • Healthcare
July 10, 2026 at 15:30 UTC
About Fresenius Medical Care AG
Fresenius Medical Care AG & Co. KGaA delivers kidney care services and related medical products through healthcare delivery and care facilities. On XETRA as FME.DE, the company combines clinic-based care with dialysis equipment, consumables, and support services, and generated EUR 19.6 billion of revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Fresenius Medical Care AG's Technical Indicators Summary
| Indicator | Value |
|---|---|
RSI (14) | 61.72 |
Stochastic %K (14, 3, 3) | 79.98 |
CCI (20) | 115.82 |
WPR (14) | -19.83 |
Momentum (10) | 1.07 |
MFI | 66.71 |
MACD Level (12, 26) | 0.77 |
Bollinger Bands | $39.61 - $42.64 |
ATR (14) | $0.95 (2.26%) |
ADX (14) | 15.19 |
OBV | 8,415,014 |
Classic Pivot Point | $41.83 |
Fibonacci Pivot Point | $41.83 |
Simple Moving Averages | $38.95 - $41.13(5 indicators) |
Exponential Moving Averages | $39.58 - $41.41(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The day concluded with FMEd hovering close to the prior 41.84, holding a tiny 0.19% gap. Into the bell, a small sector dip of -0.66% left a soft macro backdrop for FMEd. The day wrapped with modest participation in FMEd, as overall volume reached only 0.34× average.
Trading Volume
Below avg (735.0K)
251.6K
vs S&P 500 Today
Moderate Outperformance
+0.15%
52-Week Position
Mid-range
55.3%
Updated: July 10, 2026 at 15:04 UTC
Quote Summary
FMEd Headlines
EU review puts Tavneos approval at risk
June 26, 2026
Key corporate and policy moves on Apr. 24
April 24, 2026